Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Feb;105(2):261–262. doi: 10.1111/j.1476-5381.1992.tb14243.x

Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96,345, a new non-peptide NK1 receptor antagonist.

Y H Lei 1, P J Barnes 1, D F Rogers 1
PMCID: PMC1908658  PMID: 1373095

Abstract

A new non-peptide tachykinin antagonist, CP-96,345, inhibited airway plasma exudation induced in guinea-pigs by i.v. substance P in a dose-dependent manner with dose-ratios in the main bronchi of 5 at 1 nmol kg-1 and 19 at 100 nmol kg-1. At 100 nmol kg-1, CP-96,345 completely inhibited plasma exudation induced by either electrical stimulation of the cervical vagus nerves or i.v. capsaicin, indicating inhibition of the effects of endogenous tachykinins, but did not inhibit the bronchoconstrictor response to neurokinin A, suggesting selectivity for NK1 receptors. CP-96,345 may be useful in examining the role of endogenous tachykinins in vivo.

Full text

PDF
261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Advenier C., Naline E., Drapeau G., Regoli D. Relative potencies of neurokinins in guinea pig trachea and human bronchus. Eur J Pharmacol. 1987 Jul 9;139(2):133–137. doi: 10.1016/0014-2999(87)90244-5. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J. Asthma as an axon reflex. Lancet. 1986 Feb 1;1(8475):242–245. doi: 10.1016/s0140-6736(86)90777-4. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J., Belvisi M. G., Rogers D. F. Modulation of neurogenic inflammation: novel approaches to inflammatory disease. Trends Pharmacol Sci. 1990 May;11(5):185–189. doi: 10.1016/0165-6147(90)90112-l. [DOI] [PubMed] [Google Scholar]
  4. Chung K. F., Rogers D. F., Barnes P. J., Evans T. W. The role of increased airway microvascular permeability and plasma exudation in asthma. Eur Respir J. 1990 Mar;3(3):329–337. [PubMed] [Google Scholar]
  5. Lundberg J. M., Saria A. Capsaicin-sensitive vagal neurons involved in control of vascular permeability in rat trachea. Acta Physiol Scand. 1982 Aug;115(4):521–523. doi: 10.1111/j.1748-1716.1982.tb07116.x. [DOI] [PubMed] [Google Scholar]
  6. McLean S., Ganong A. H., Seeger T. F., Bryce D. K., Pratt K. G., Reynolds L. S., Siok C. J., Lowe J. A., 3rd, Heym J. Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist. Science. 1991 Jan 25;251(4992):437–439. doi: 10.1126/science.1703324. [DOI] [PubMed] [Google Scholar]
  7. Rogers D. F., Belvisi M. G., Aursudkij B., Evans T. W., Barnes P. J. Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs. Br J Pharmacol. 1988 Dec;95(4):1109–1116. doi: 10.1111/j.1476-5381.1988.tb11745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Snider R. M., Constantine J. W., Lowe J. A., 3rd, Longo K. P., Lebel W. S., Woody H. A., Drozda S. E., Desai M. C., Vinick F. J., Spencer R. W. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 1991 Jan 25;251(4992):435–437. doi: 10.1126/science.1703323. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES